Sun Oct 12 00:15:00 UTC 2025: Okay, here’s a news article based on the provided text, following the prompt’s instructions:

**News Article:**

**India Needs Wider Access to Automated Insulin Delivery for Type 1 Diabetes, Expert Argues**

**CHENNAI, October 12, 2025** – India, home to the largest population of children and adolescents with Type 1 diabetes globally (301,000 under 20), must prioritize wider adoption of automated insulin delivery (AID) systems and continuous glucose monitoring (CGM) to improve patient care, according to Dr. Banshi Saboo, Chairman of the International Diabetes Federation – South East Asia.

Dr. Saboo made his remarks while delivering the inaugural “Professor M. Viswanathan Centenary Award and Oration” on “Managing Type 1 Diabetes – Current Status and Beyond” on Saturday. He stressed that AID systems represent the current standard of care for glycemic management in youth and adults with Type 1 diabetes.

Despite the availability of CGM technology, its high cost remains a significant barrier to access for many in India. Dr. Saboo suggested that local production could significantly lower prices. He also called for the establishment of state and district-level registries for Type 1 diabetes to better understand the disease’s prevalence and impact. Addressing affordability and accessibility gaps, and raising public awareness, were also identified as crucial steps.

Acknowledging the challenges of disparity in healthcare quality, access to drugs and technology in India, Dr. Saboo emphasized that with good control, the prevention of diabetic ketoacidosis and severe hypoglycemia can be achieved.

A. Somasundaram, Director of Public Health and Preventive Medicine, highlighted the Tamil Nadu government’s existing health initiatives, including comprehensive screening programs for hypertension and diabetes conducted at various healthcare facilities. He outlined efforts to expand screening for complications like neuropathy and kidney disease through programs like “Padham Padhukappom Thittam” and “Siruneeragam Padhukappu Thittam.”

Somasundaram also noted the current low detection rates for gestational diabetes (1-2% vs. an estimated prevalence of 8-10%) and outlined plans to improve detection under the gestational diabetes programme. He suggested collaborations for training primary healthcare physicians and nurses to improve screening and understanding of the nuances of diabetes and its complications.

The oration was organized by M.V. Diabetes and Professor M. Viswanathan Diabetes Research Centre. Vijay Viswanathan, Head and chief physician of M.V. Diabetes and president of Research Society for the Study of Diabetes in India was present, along with dean S.N. Narasingan and associate dean Jayashree Gopal of the Professor M. Viswanathan Diabetes Research Centre.

Read More